Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

22GI

3D1 Fab in complex with pepAVVNQN

Summary for 22GI
Entry DOI10.2210/pdb22gi/pdb
DescriptorLight chain of 3D1, Heavy chain of 3D1, ALA-VAL-VAL-ASN-GLN-ASN, ... (5 entities in total)
Functional Keywordssads-cov, antibody, spike, hr1, viral protein/immune system, viral protein-immune system complex
Biological sourceHomo sapiens
More
Total number of polymer chains12
Total formula weight184204.31
Authors
Lei, Y. (deposition date: 2026-01-09, release date: 2026-04-15)
Primary citationZhang, L.,Liang, Z.,Yang, G.,Yan, L.
Elucidating the Molecular Mechanism of 3D1 Antibody Binding to a Swine Enteric Coronavirus Antigen.
Viruses, 18:-, 2026
Cited by
PubMed Abstract: The broadly neutralizing monoclonal antibody 3D1 potently neutralizes SADS-CoV by targeting a conserved epitope within the heptad repeat 1 (HR1) domain of the viral spike protein. Structural and biophysical analyses demonstrate that 3D1 binds with high affinity to a specific linear β-turn motif (residues A804-N809) in HR1. High-resolution crystallography reveals that this motif sits within a deep, electrostatically complementary paratope groove. Critically, 3D1 binding competitively inhibits the essential interaction between HR1 and HR2. Notably, its recognition is not dependent on HR1's native helical conformation, as it maintains strong binding to conformationally constrained, stapled helical peptides. Collectively, the data indicate that 3D1 neutralizes by capturing a pre-hairpin intermediate state of HR1-a transition state between prefusion and postfusion forms-thereby sterically blocking the formation of the stable postfusion six-helix bundle that is essential for membrane fusion. This work defines a precise, structure-dependent neutralizing epitope and elucidates a mechanism of action that involves trapping a key fusion intermediate, offering a valuable template for the design of broad-spectrum coronavirus therapeutics.
PubMed: 41754551
DOI: 10.3390/v18020208
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.64 Å)
Structure validation

256789

PDB entries from 2026-07-22

PDB statisticsPDBj update infoContact PDBjnumon